PX
72
-4
CINF
57
-3
TSCO
55
-4
WM
73
2
RF
73
-4
PLD
41
-9
HST
43
-4
CCL
78
-3
WFC
80
-2
HAL
39
-2
NOC
38
3
WBA
41
-2
CFG
86
-2
WY
25
-2
IVZ
53
-5
EXPE
64
-3
UAL
51
-3
AMG
54
-4
VNO
57
-2
MA
72
-2
PX
72
-4
CINF
57
-3
TSCO
55
-4
WM
73
2
RF
73
-4
PLD
41
-9
HST
43
-4
CCL
78
-3
WFC
80
-2
HAL
39
-2
NOC
38
3
WBA
41
-2
CFG
86
-2
WY
25
-2
IVZ
53
-5
EXPE
64
-3
UAL
51
-3
AMG
54
-4
VNO
57
-2
MA
72
-2
Financhill
Back

Plus Therapeutics Stock Price Chart

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
25

PSTV
Plus Therapeutics

Last Price:
$0.33
Seasonality Move:
-16.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Portfolio's Boring. This Company Isn't And It's Early

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing buying pressure, which is a positive indicator for future bullish movement.

Plus Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.51 Sell
20-day SMA: 0.63 Sell
50-day SMA: 0.8 Sell
200-day SMA: 1.17 Sell
8-day EMA: 0.47 Sell
20-day EMA: 0.59 Sell
50-day EMA: 0.75 Sell
200-day EMA: 1.18 Sell

Plus Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 33.25 Sell
Chaikin Money Flow: 7235424 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.49 - 0.79) Sell
Bollinger Bands (100): (0.66 - 1.28) Sell

Plus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Plus Therapeutics Stock

Is Plus Therapeutics Stock a Buy?

  • Plus Therapeutics share price is 0.32 while PSTV 8-day simple moving average is 0.51, which is a Sell signal.
  • The stock price of PSTV is 0.32 while Plus Therapeutics 20-day SMA is 0.63, which makes it a Sell.
  • Plus Therapeutics 50-day simple moving average is 0.80 while PSTV share price is 0.32, making it a Sell technically.
  • PSTV stock price is 0.32 and Plus Therapeutics 200-day simple moving average is 1.17, creating a Sell signal.

PSTV Technical Analysis vs Fundamental Analysis

Sell
25
Plus Therapeutics (PSTV) is a Sell

Is Plus Therapeutics a Buy or a Sell?

  • Plus Therapeutics stock is rated a Sell
    The current Plus Therapeutics [PSTV] share price is $0.32. The Score for PSTV is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.

Plus Therapeutics Stock Info

Market Cap:
5.4M
Price in USD:
0.32
Share Volume:
7.9M

Plus Therapeutics 52-Week Range

52-Week High:
2.67
52-Week Low:
0.24
Sell
25
Plus Therapeutics (PSTV) is a Sell

Plus Therapeutics Share Price Forecast

Is Plus Therapeutics Stock a Buy?

  • Plus Therapeutics share price is 0.32 while PSTV 8-day exponential moving average is 0.47, which is a Sell signal.
  • The stock price of PSTV is 0.32 while Plus Therapeutics 20-day EMA is 0.59, which makes it a Sell.
  • Plus Therapeutics 50-day exponential moving average is 0.75 while PSTV share price is 0.32, making it a Sell technically.
  • PSTV stock price is 0.32 and Plus Therapeutics 200-day simple moving average is 1.18, creating a Sell signal.

Fundamental Analysis of Plus Therapeutics

Is Plus Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.03 per share, an increase this year of $1.10 per share, and an increase next year of $0.08 per share.

Technical Analysis of Plus Therapeutics

Should I short Plus Therapeutics stock?

* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.